Changes to the PBS listings for Opdualag and Vyxeos

1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2024

1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Life changing endometriosis treatment now cheaper

1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...

Read more →

Australians benefit from new and expanded medicines on the PBS

20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2024 update

1 November 2024 - The November 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Heart attack survivors find new treatment for recurrence risk

4 October 2024 - Mike Lynch was only 12 when his mother died of cardiovascular disease, in the years following he ...

Read more →

New cheaper medicines for auto-immune conditions, cancer and heart disease

8 October 2024 - Australians with types of vasculitis, leukaemia, heart disease, ulcerative colitis and arthritis now have access to ...

Read more →

World first cancer treatment now accessible for hundreds more Aussies as prices slashed with addition to the PBS

4 October 2024 - A world-first cancer treatment, discovered in Melbourne, has been added to the PBS. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 October 2024

1 October 2024 - The October 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New and expanded PBS listings for Fabry disease and kidney cancer

9 September 2024 - Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access ...

Read more →

Schedule of Pharmaceutical Benefits - 1 September 2024

The September 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Life prolonging breast cancer drug receives expanded access on the PBS

28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life ...

Read more →

New PBS listing for migalastat (Galafold) for the treatment of Fabry disease

19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...

Read more →

Cheaper medicines for rare genetic disorders and cancer

12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...

Read more →

PBS listing for Australians with hereditary transthyretin-mediated amyloidosis with polyneuropathy

1 August 2024 - Medison Pharma, alongside their partner Alnylam Pharmaceuticals, are pleased to announce that from 1 August 2024, ...

Read more →